WISDOM
2014
Withdrawal of Inhaled Steroids During Optimised Bronchodilator Management
In 2,485 patients with severe COPD on triple therapy, stepwise withdrawal of inhaled corticosteroids was non-inferior for time to moderate-or-severe exacerbation compared with continued ICS.
Result
Efficacy: Time to first moderate or severe exacerbationHR 1.06 (95% CI 0.94-1.19)
Below 1 favours stepwise withdrawal of inhaled corticosteroids, above 1 favours continued ICS.
Also reported: FEV1 declined 38 mL more with withdrawal.
- Subtopic
- ICS withdrawal
- Design
- Multicentre RCT
- Relevance
- Important: one of several pillars.
- Cited in
- GOLD 2023 COPD
- Source
- Magnussen H, et al. N Engl J Med. 2014;371(14):1285-1294.doi 10.1056/NEJMoa1407154
Discussion & critique
ICS can be withdrawn in many COPD patients on dual bronchodilator therapy; risk concentrates in eosinophilia ≥300/µL.